Breaking News Instant updates and real-time market news.

TXMD

TherapeuticsMD

$6.31

0.3718 (6.26%)

14:05
08/17/17
08/17
14:05
08/17/17
14:05

TherapeuticsMD call volume above normal and directionally bullish

Bullish option flow detected in TherapeuticsMD with 2,661 calls trading, 3x expected, and implied vol increasing almost 2 points to 86.15%. Dec-17 5 calls and Mar-18 7.5 calls are the most active options, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 0.03. Earnings are expected on November 2nd.

  • 03

    Nov

TXMD TherapeuticsMD
$6.31

0.3718 (6.26%)

08/17/17
DBAB
08/17/17
NO CHANGE
Target $10
DBAB
Buy
TherapeuticsMD remains confident in TX-004 safety, says Deutsche Bank
Deutsche Bank analyst Esther Rajavelu spoke to TherapeuticsMD after the publication of the National Institutes of Health-sponsored observational study on long-term, real world use of vaginal estrogens. Management remains confident that the observational data is sufficient to demonstrate endometrial safety for TX-004 and could be a satisfactory response to the complete response letter issued in May requesting long-term safety data, Rajavelu tells investors in a research note. The data from the cohort of 32,433 women with an intact uterus demonstrate that risks of endometrial cancer and other serious adverse events were not significantly different between women who used vaginal estrogens and those who did not, the analyst writes. She continues to model TX-004 will launch conservatively in 2019. The analyst has a Buy rating on TherapeuticsMD with a $10 price target.
08/11/17
STFL
08/11/17
NO CHANGE
STFL
TherapeuticsMD launch may be only delayed six months, says Stifel
After the FDA said it would review additional data from TherapeuticsMD on vaginal estrogen use and set a November 3 meeting date with the company, Stifel analyst Annabel Samimy thinks the FDA's moves indicate "the data are meaningful enough to satisfy the safety question in the CRL." She thinks that the company's program may be no more than six months delayed from the original plan, and she keeps a $20 price target and a Buy rating on the shares.
08/11/17
DBAB
08/11/17
NO CHANGE
Target $10
DBAB
Buy
TherapeuticsMD announcement a 'small positive,' says Deutsche Bank
Deutsche Bank analyst Esther Rajavelu views TherapeuticsMD's announcement that the FDA will review in detail, as part of the data package for TX-004, a large NIH-sponsored observational study on long-term, real world use of vaginal estrogens as a "small positive." While the analyst remains cautious on the timing and outcome of the review, she sees the news as an "incremental step in the right direction." Rajavelu continues to model for a TX-004 launch in 2019. The analyst keeps a Buy rating on TherapeuticsMD with a $10 price target.
08/04/17
OPCO
08/04/17
NO CHANGE
Target $10
OPCO
Outperform
TherapeuticsMD talks with FDA increasingly collaborative, says Oppenheimer
After TherapeuticsMD provided an update on the regulatory process for both TX-004HR and TX-001HR, Oppenheimer analyst Jay Olson says he believes the narrative between the company and the FDA has become "more collaborative." This suggests next week's potential update on TX-004HR could be favorable, Olson tells investors in a research note. The analyst keeps an Outperform rating on TherapeuticsMD with a $10 price target.

TODAY'S FREE FLY STORIES

AAPL

Apple

$176.04

-0.16 (-0.09%)

13:22
01/17/18
01/17
13:22
01/17/18
13:22
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple sees creating over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:21
01/17/18
01/17
13:21
01/17/18
13:21
Hot Stocks
Apple to announce new U.S. campus location later this year »

Apple in its statement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

ICHR

Ichor Holdings

$25.60

0.86 (3.48%)

13:18
01/17/18
01/17
13:18
01/17/18
13:18
Recommendations
Ichor Holdings analyst commentary  »

Ichor Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 07

    Feb

IPSEY

Ipsen

13:18
01/17/18
01/17
13:18
01/17/18
13:18
Hot Stocks
Ipsen: Onivyde+-FU/LV improved overall survival in Phase 3 study »

Ipsen Biopharmaceuticals,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

$NSD

NASDAQ Market Internals

13:17
01/17/18
01/17
13:17
01/17/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
01/17/18
01/17
13:16
01/17/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$63.42

0.92 (1.47%)

13:15
01/17/18
01/17
13:15
01/17/18
13:15
Hot Stocks
Wells Fargo announces retirement of chief risk officer Mike Loughlin »

Wells Fargo & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACLS

Axcelis

$30.30

1.15 (3.95%)

, AMAT

Applied Materials

$54.50

1.05 (1.96%)

13:14
01/17/18
01/17
13:14
01/17/18
13:14
Recommendations
Axcelis, Applied Materials analyst commentary  »

Axcelis presentation an…

ACLS

Axcelis

$30.30

1.15 (3.95%)

AMAT

Applied Materials

$54.50

1.05 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

AVGO

Broadcom

$263.25

-1.04 (-0.39%)

13:12
01/17/18
01/17
13:12
01/17/18
13:12
Periodicals
Broadcom probed by FTC over negotiations with customers, WSJ reports »

The FTC is probing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLM

Sallie Mae

$11.47

-0.24 (-2.05%)

13:08
01/17/18
01/17
13:08
01/17/18
13:08
Technical Analysis
Technical Earnings Preview: SLM Corp in middle of range before news »

Shares have been trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:08
01/17/18
01/17
13:08
01/17/18
13:08
Hot Stocks
Apple announces new U.S. investments, sees $38B of repatriation taxes »

Apple announced a new set…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

13:05
01/17/18
01/17
13:05
01/17/18
13:05
General news
Treasury Action: early March bills continue to underperform »

Treasury Action: early…

FOX

21st Century Fox

$35.79

-0.58 (-1.59%)

, FOXA

21st Century Fox

$36.29

-0.44 (-1.20%)

13:04
01/17/18
01/17
13:04
01/17/18
13:04
Periodicals
FoxNext acquires game developer Cold Iron Studios, Polygon says »

FoxNext Games, the video…

FOX

21st Century Fox

$35.79

-0.58 (-1.59%)

FOXA

21st Century Fox

$36.29

-0.44 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 07

    Feb

  • 07

    Feb

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:02
01/17/18
01/17
13:02
01/17/18
13:02
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple breaking ground…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:01
01/17/18
01/17
13:01
01/17/18
13:01
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple sees investing over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:01
01/17/18
01/17
13:01
01/17/18
13:01
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple announces new set…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

UPS

UPS

$133.62

0.74 (0.56%)

13:00
01/17/18
01/17
13:00
01/17/18
13:00
Options
Notable call spread in UPS as shares deliver profits »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AA

Alcoa

$56.35

0.11 (0.20%)

12:57
01/17/18
01/17
12:57
01/17/18
12:57
Technical Analysis
Technical Earnings Preview: Alcoa near 52-week high before news »

Ahead of earnings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

AAPL

Apple

$176.19

-0.9 (-0.51%)

, BMWYY

BMW

$37.64

1.125 (3.08%)

12:51
01/17/18
01/17
12:51
01/17/18
12:51
Periodicals
BMW to offer CarPlay as subscription-based service next year, The Verge says »

BMW (BMWYY) plans to…

AAPL

Apple

$176.19

-0.9 (-0.51%)

BMWYY

BMW

$37.64

1.125 (3.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

TBT

ProShares UltraShort 20+ yr Trsry

$34.72

-0.06 (-0.17%)

12:50
01/17/18
01/17
12:50
01/17/18
12:50
Options
Closing puts in the ProShares UltraShort Longer-term Bond ETF »

Closing puts in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:50
01/17/18
01/17
12:50
01/17/18
12:50
General news
U.S. equities extended their bounce »

U.S. equities extended…

ERJ

Embraer

$24.67

-0.1125 (-0.45%)

, BA

Boeing

$347.06

11.9016 (3.55%)

12:48
01/17/18
01/17
12:48
01/17/18
12:48
Periodicals
Embraer tells Bloomberg no guarantee Boeing talks with result in deal »

Embraer (ERJ), in an…

ERJ

Embraer

$24.67

-0.1125 (-0.45%)

BA

Boeing

$347.06

11.9016 (3.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

ASML

ASML

$186.38

5.51 (3.05%)

, LRCX

Lam Research

$190.39

1.88 (1.00%)

12:46
01/17/18
01/17
12:46
01/17/18
12:46
Hot Stocks
ASML results pull semiconductor equipment maker shares higher »

Shares of semiconductor…

ASML

ASML

$186.38

5.51 (3.05%)

LRCX

Lam Research

$190.39

1.88 (1.00%)

KLAC

KLA-Tencor

$107.66

0.37 (0.34%)

AMAT

Applied Materials

$54.50

1.05 (1.96%)

TER

Teradyne

$46.51

1.2 (2.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

BCS

Barclays

$11.01

0.045 (0.41%)

12:45
01/17/18
01/17
12:45
01/17/18
12:45
Periodicals
Barclays slashes up to 100 senior investment bank staff, Bloomberg says »

Barclays is cutting up to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

12:41
01/17/18
01/17
12:41
01/17/18
12:41
Technical Analysis
Technical Earnings Preview: Kinder Morgan in uptrend before results »

The stock has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.